These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22174375)

  • 1. Alum adjuvant: some of the tricks of the oldest adjuvant.
    Kool M; Fierens K; Lambrecht BN
    J Med Microbiol; 2012 Jul; 61(Pt 7):927-934. PubMed ID: 22174375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aluminum compounds as vaccine adjuvants.
    Gupta RK
    Adv Drug Deliv Rev; 1998 Jul; 32(3):155-172. PubMed ID: 10837642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant properties of aluminum and calcium compounds.
    Gupta RK; Rost BE; Relyveld E; Siber GR
    Pharm Biotechnol; 1995; 6():229-48. PubMed ID: 7551219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alum's adjuvant action: grease is the word.
    Mbow ML; De Gregorio E; Ulmer JB
    Nat Med; 2011 Apr; 17(4):415-6. PubMed ID: 21475229
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study of stress-mediated immunological functions with the adjuvanticity of alum.
    Wang Y; Rahman D; Lehner T
    J Biol Chem; 2012 May; 287(21):17152-17160. PubMed ID: 22474329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contamination of DNase Preparations Confounds Analysis of the Role of DNA in Alum-Adjuvanted Vaccines.
    Noges LE; White J; Cambier JC; Kappler JW; Marrack P
    J Immunol; 2016 Aug; 197(4):1221-30. PubMed ID: 27357147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells.
    Kool M; Soullié T; van Nimwegen M; Willart MA; Muskens F; Jung S; Hoogsteden HC; Hammad H; Lambrecht BN
    J Exp Med; 2008 Apr; 205(4):869-82. PubMed ID: 18362170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine.
    Sugai T; Mori M; Nakazawa M; Ichino M; Naruto T; Kobayashi N; Kobayashi Y; Minami M; Yokota S
    Vaccine; 2005 Nov; 23(46-47):5450-6. PubMed ID: 16006019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory properties of the vaccine adjuvant alum.
    Oleszycka E; Lavelle EC
    Curr Opin Immunol; 2014 Jun; 28():1-5. PubMed ID: 24463269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate-based immune adjuvants.
    Petrovsky N; Cooper PD
    Expert Rev Vaccines; 2011 Apr; 10(4):523-37. PubMed ID: 21506649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vaccine adjuvant alum inhibits IL-12 by promoting PI3 kinase signaling while chitosan does not inhibit IL-12 and enhances Th1 and Th17 responses.
    Mori A; Oleszycka E; Sharp FA; Coleman M; Ozasa Y; Singh M; O'Hagan DT; Tajber L; Corrigan OI; McNeela EA; Lavelle EC
    Eur J Immunol; 2012 Oct; 42(10):2709-19. PubMed ID: 22777876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection.
    Azizi H; Mirzaeei H; Nasiri AA; Bazi A; Mirzapour A; Khatami M; Nahavandi KH; Azimi A; Yaghoobi H
    Exp Parasitol; 2018 Jun; 189():66-71. PubMed ID: 29729492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Illuminating alum.
    Schubert C
    Nat Med; 2009 Sep; 15(9):985. PubMed ID: 19734863
    [No Abstract]   [Full Text] [Related]  

  • 14. CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D.
    Rankin R; Pontarollo R; Gomis S; Karvonen B; Willson P; Loehr BI; Godson DL; Babiuk LA; Hecker R; van Drunen Littel-van den Hurk S
    Vaccine; 2002 Jul; 20(23-24):3014-22. PubMed ID: 12126915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cationic lipid, diC14 amidine, extends the adjuvant properties of aluminum salts through a TLR-4- and caspase-1-independent mechanism.
    Wilmar A; Lonez C; Vermeersch M; Andrianne M; Pérez-Morga D; Ruysschaert JM; Vandenbranden M; Leo O; Temmerman ST
    Vaccine; 2012 Jan; 30(2):414-24. PubMed ID: 22075093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG DNA induces stronger immune responses with less toxicity than other adjuvants.
    Weeratna RD; McCluskie MJ; Xu Y; Davis HL
    Vaccine; 2000 Mar; 18(17):1755-62. PubMed ID: 10699323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparate adjuvant properties among three formulations of "alum".
    Cain DW; Sanders SE; Cunningham MM; Kelsoe G
    Vaccine; 2013 Jan; 31(4):653-60. PubMed ID: 23200935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyethylenimine-coated PLGA nanoparticles-encapsulated Angelica sinensis polysaccharide as an adjuvant for H9N2 vaccine to improve immune responses in chickens compared to Alum and oil-based adjuvants.
    Gu P; Wusiman A; Zhang Y; Cai G; Xu S; Zhu S; Liu Z; Hu Y; Liu J; Wang D
    Vet Microbiol; 2020 Dec; 251():108894. PubMed ID: 33096470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation of a recombinant HIV-1 polytope candidate vaccine with naloxone/alum mixture: induction of multi-cytokine responses with a higher regulatory mechanism.
    Fathi M; Nezamzadeh R; Abdollahpour-Alitappeh M; Yazdi MH; Khoramabadi N; Mahdavi M
    APMIS; 2021 Aug; 129(8):480-488. PubMed ID: 33539574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Combination Vaccine Adjuvant System Alum/c-di-AMP Results in Quantitative and Qualitative Enhanced Immune Responses Post Immunization.
    Ebensen T; Delandre S; Prochnow B; Guzmán CA; Schulze K
    Front Cell Infect Microbiol; 2019; 9():31. PubMed ID: 30838180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.